Dr. Jennifer Mitchell, a UCSF neurology expert, and Dr. Sarah Abedi, a dedicated psychedelic researcher, discuss the evolving landscape of psychedelic medicine. They explore the promising potential of MDMA-assisted therapy for PTSD and the historical context of psychedelics, tracing their tumultuous past and recent resurgence. The conversation highlights the complexities of research, ongoing FDA approval hurdles, and the ethical considerations surrounding therapeutic practices. Ultimately, they envision a future where psychedelics provide innovative solutions for mental health treatment.